(Q37727778)

22 August 2017

1 reference

title

p53-family proteins and their regulators: hubs and spokes in tumor suppression (English)

1 reference

22 August 2017

L Collavin

1

1 reference

PubMed ID

20379196

22 August 2017

A Lunardi

series ordinal

2

1 reference

PubMed ID

20379196

22 August 2017

G Del Sal

series ordinal

3

1 reference

22 August 2017

9 April 2010

1 reference

Cell Death & Differentiation

22 August 2017

1 reference

22 August 2017

17

1 reference

22 August 2017

6

1 reference

22 August 2017

901-911

1 reference

https://scigraph.springernature.com/pub.10.1038/cdd.2010.35

22 August 2017

0 references

cites work

The first 30 years of p53: growing ever more complex

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

21 January 2018

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Cytoplasmic functions of the tumour suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The expanding universe of p53 targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

On the shoulders of giants: p63, p73 and the rise of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 Is essential for the proliferative potential of stem cells in stratified epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

TAp63 prevents premature aging by promoting adult stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

TAp63 induces senescence and suppresses tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 and p73 transcriptionally regulate genes involved in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 and p73 in human cancer: defining the network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

TAp73 knockout shows genomic instability with infertility and tumor suppressor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p63 protects the female germ line during meiotic arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Li-Fraumeni syndrome: a p53 family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p53 ubiquitination: Mdm2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Inactivation of the p53 pathway in retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulation of p63 function by Mdm2 and MdmX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

MDM2 and MDMX bind and stabilize the p53-related protein p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Design of a novel MDM2 binding peptide based on the p53 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

c-Abl phosphorylates Hdmx and regulates its interaction with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The notch regulator MAML1 interacts with p53 and functions as a coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

NUMB controls p53 tumour suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The multiple levels of regulation by p53 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Trim24 targets endogenous p53 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulation of p53: TRIM24 enters the RING.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The SCF FSN-1 ubiquitin ligase controls germline apoptosis through CEP-1/p53 in C. elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The E3 ubiquitin ligase Itch controls the protein stability of p63

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The ubiquitin-protein ligase Itch regulates p73 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Pin1 links the activities of c-Abl and p300 in regulating p73 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

PCAF is a coactivator for p73-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p300 regulates p63 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Acetylation is indispensable for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Histone deacetylases specifically down-regulate p53-dependent gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A novel cofactor for p300 that regulates the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A transcription co-factor integrates cell adhesion and motility with the p53 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p53-cofactor JMY is a multifunctional actin nucleation factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A TPR motif cofactor contributes to p300 activity in the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Arginine methylation regulates the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulation of p53 functions: let's meet at the nuclear bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Axin determines cell fate by controlling the p53 activation threshold after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The transcriptional repressor hDaxx potentiates p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

ASPP1 and ASPP2: common activators of p53 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

ASPP proteins specifically stimulate the apoptotic function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

ASPP: a new family of oncogenes and tumour suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Cabin1 restrains p53 activity on chromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

MSL2 promotes Mdm2-independent cytoplasmic localization of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Monoubiquitylation promotes mitochondrial p53 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Mutant p53 protein localized in the cytoplasm inhibits autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The coordinate regulation of the p53 and mTOR pathways in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

RETRACTED: p73alpha regulation by Chk1 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

DeltaNp73 modulates nerve growth factor-mediated neuronal differentiation through repression of TrkA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

USP10 regulates p53 localization and stability by deubiquitinating p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

SnapShot: p53 posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The complexity of p53 stabilization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

A complex barcode underlies the heterogeneous response of p53 to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

MDM2 and MDMX can interact differently with ARF and members of the p53 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

p53 ancestry: gazing through an evolutionary lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

A subset of p53-deficient embryos exhibit exencephaly

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

20 years studying p53 functions in genetically engineered mice

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

p73 suppresses polyploidy and aneuploidy in the absence of functional p53

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

Dual-site regulation of MDM2 E3-ubiquitin ligase activity

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

Crosstalk of Notch with p53 and p63 in cancer growth control

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

DeltaNp63 induces beta-catenin nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.35

7 January 2021

Identifiers

DOI

10.1038/CDD.2010.35

1 reference

22 August 2017

1 reference

PubMed ID

20379196